ARYx Therapeutics Inc
OTC:ARYX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
ARYx Therapeutics Inc
OTC:ARYX
|
US |
|
Bank Pan Indonesia Tbk PT
IDX:PNBN
|
ID |
|
O
|
Opus One Gold Corp
XTSX:OOR
|
CA |
|
Vanda Pharmaceuticals Inc
NASDAQ:VNDA
|
US |
|
Lycopodium Ltd
ASX:LYL
|
AU |
|
Idaho Copper Corp
OTC:COPR
|
US |
|
Kuros Biosciences AG
SIX:KURN
|
CH |
|
Australian Finance Group Ltd
ASX:AFG
|
AU |
|
Fursys Inc
KRX:016800
|
KR |
Shareholder Yield
Current shareholder yield for ARYX is
hidden
.
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
ARYX Price
ARYx Therapeutics Inc
| Average Annual Return | -39.34% |
| Standard Deviation of Annual Returns | 45.42% |
| Max Drawdown | -100% |
| Market Capitalization | 33.5 USD |
| Shares Outstanding | 66 924 |
| Percentage of Shares Shorted | 0.39% |
